These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1723003)

  • 1. Antisense oligonucleotide derivatives as gene-targeted drugs.
    Knorre DG; Vlassov VV
    Biomed Sci; 1990 Apr; 1(4):334-43. PubMed ID: 1723003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hitchhiker's guide to antisense and nonantisense biochemical pathways.
    Branch AD
    Hepatology; 1996 Dec; 24(6):1517-29. PubMed ID: 8938189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
    Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
    Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.
    Jen KY; Gewirtz AM
    Stem Cells; 2000; 18(5):307-19. PubMed ID: 11007915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology].
    Kausch I; Böhle A
    Aktuelle Urol; 2003 Dec; 34(7):458-68. PubMed ID: 14655082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to chemotherapy based on molecular biology and nucleic acid chemistry: Matagen (masking tape for gene expression).
    Miller PS; Ts'o PO
    Anticancer Drug Des; 1987 Oct; 2(2):117-28. PubMed ID: 3329522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of bifunctional oligonucleotide intercalator conjugates as inhibitors of gene expression.
    Helene C; Thuong NT
    Nucleic Acids Symp Ser; 1991; (24):133-7. PubMed ID: 1668684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotides.
    Herdewijn P
    Verh K Acad Geneeskd Belg; 1996; 58(4):359-81. PubMed ID: 8956554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription.
    DeMoor JM; Vincent MD; Collins OM; Koropatnick J
    Exp Cell Res; 1998 Aug; 243(1):11-21. PubMed ID: 9716444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro toxicology and pharmacokinetics of antisense oligonucleotides.
    Crooke RM
    Anticancer Drug Des; 1991 Dec; 6(6):609-46. PubMed ID: 1772572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Napthalimidobenzamide DB-51630: a novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity.
    Suzuki K; Nagasawa H; Uto Y; Sugimoto Y; Noguchi K; Wakida M; Wierzba K; Terada T; Asao T; Yamada Y; Kitazato K; Hori H
    Bioorg Med Chem; 2005 Jun; 13(12):4014-21. PubMed ID: 15911314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
    Mahato RI; Cheng K; Guntaka RV
    Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo.
    Faria M; Spiller DG; Dubertret C; Nelson JS; White MR; Scherman D; Hélène C; Giovannangeli C
    Nat Biotechnol; 2001 Jan; 19(1):40-4. PubMed ID: 11135550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide nucleic acids as therapeutic agents.
    Nielsen PE
    Curr Opin Struct Biol; 1999 Jun; 9(3):353-7. PubMed ID: 10361091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the antisense oligonucleotide technique in neuropsychopharmacology research].
    Yamada M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):129-38. PubMed ID: 8905802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of gene expression in viruses and protozoan parasites by antisense oligonucleotides.
    Toulmé JJ; Bourget C; Compagno D; Yurchenko L
    Parasitology; 1997; 114 Suppl():S45-59. PubMed ID: 9309768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential role for antisense oligonucleotide analogues in the development of oncogene targeted cancer chemotherapy.
    Tidd DM
    Anticancer Res; 1990; 10(5A):1169-82. PubMed ID: 2241097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis of alternating alpha,beta-oligodeoxyribonucleotides with alternating (3'-->3')- and (5'-->5')-internucleotic linkages as potential therapeutic agents.
    Koga M; Geyer SJ; Regan JB; Beaucage SL
    Nucleic Acids Symp Ser; 1993; (29):3-4. PubMed ID: 8247779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis.
    Zhang H; Cook J; Nickel J; Yu R; Stecker K; Myers K; Dean NM
    Nat Biotechnol; 2000 Aug; 18(8):862-7. PubMed ID: 10932156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.